AX for Pharma’s parent company, To-Increase, has been recognized with Microsoft’s Inner Circle Award for Business Applications.
“AX for Pharma is delighted that To-Increase is part of the Microsoft Inner Circle, comprising the top 1% of Microsoft Partners worldwide. This is the 15th time To-Increase has been added to Microsoft’s Inner Circle,” said CEO Andrea Ruosi.
In April this year, AX for Pharma (AXP) was acquired by To-Increase, a leading global Independent Software Vendor (ISV) for Microsoft Dynamics 365 (D365) business applications. The acquisition has enabled AXP to leverage To-Increase’s strong partner channel and long-standing Microsoft alliance.
Notably, AXP is a Microsoft Dynamics 365 ISV and System Integrator for the Life Sciences industry that has been collaborating directly with Microsoft since 2011 as one of the first five ISVs certified on Dynamics AX 2012 (To-Increase was another of those five).
“At AX for Pharma, we strive to enhance the pharmaceutical, biotech, and medical devices sectors by delivering top-notch solutions. And we’ve been able to do that with our 15 years of partnership with Microsoft. Over the years, we’ve cultivated deep knowledge and capabilities on Microsoft applications to provide exceptional services to the Life Sciences industry. The recognition of our parent company To-Increase in Microsoft’s Inner Circle further strengthens our collaboration with Microsoft and opens up opportunities for cooperation, knowledge sharing, and mutual growth,” said Andrea Ruosi.
Founded in 2008, AX for Pharma is a provider of Life Sciences ERP solutions built on top of Microsoft Dynamics 365. The company offers a range of add-on modules that support a wide array of pharma-specific workflows, including supply chain, quality management, and clinical supplies. The company is headquartered in Milan, Italy (Europe), with North American headquarters in Tampa, Florida, and offices in Sydney (Australia).
AX for Pharma 365™ empowers Pharmaceutical, Biotech, and Medical Device companies to manufacture safer and higher-quality drugs through a cutting-edge platform powered by Microsoft Dynamics 365. Specifically engineered to meet the needs of Life Sciences companies, the AX for Pharma 365™ Enterprise Suite enables these companies to comply with industry-specific rules, adhere to good manufacturing practices, meet regulations and guidelines necessary to deliver high-quality therapeutics and keep patients safe while successfully meeting or exceeding operational and financial objectives.
Media Contact for AXP
Andrea Ruosi
[email protected]
